Evidence map›Paper›PMID 10922055›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2000

Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA.

A Michienzi, L Cagnon, I Bahner, J J Rossi

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 119 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

A MichienziDepartment of Molecular Biology, Beckman Research Institute of the City of Hope, and Graduate School of Biological Sciences, City of Hope, Duarte, CA 91010-3011, USA.
L Cagnon
I Bahner
J J Rossi
Beckman Research InstituteCity of Hope · US

Funding

COMBINATORIAL USE OF CCR5 RIBOZYMES WITH ANTI HIV1 RNASR01AI042552 · NIAID · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI ROSSI, JOHN JOSEPH · 1998 to 2019
$7.8M
Enhancing the Intracellular Functioning of HIV RibozymesR37AI029329 · NIAID · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI ROSSI, JOHN JOSEPH · 2002 to 2011
$6.7M
YEAST SYSTEM FOR DEVELOPING ANTI-HIV-1 RIBOZYMESR01AI029329 · NIAID · LOMA LINDA UNIVERSITY · PI ROSSI, JOHN JOSEPH · 1990 to 2018
$3.9M
DEVELOPMENT OF TARGETED AND STABLE HAMMERHEAD RIBOZYMESF32GM018898 · NIGMS · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI BAHNER-BERNDT, INGRID · 1997 to 1999
–
NIAID NIH HHS AI29329NIAID NIH HHS AI42552NIAID NIH HHS R01 AI029329NIAID NIH HHS R01 AI042552NIAID NIH HHS R37 AI029329NIGMS NIH HHS 5 F32 GM18898-02NIGMS NIH HHS F32 GM018898
6 · The paper itself

Abstract

The HIV regulatory proteins Tat and Rev have a nucleolar localization property in human cells. However, no functional role has been attributed to this localization. Recently it has been demonstrated that expression of Rev induces nucleolar relocalization of some protein factors involved in Rev export. Because the function of Rev is to bind HIV RNA and facilitate transport of singly spliced and unspliced RNA to the cytoplasm, it is likely that the nucleolus plays a critical role in HIV-1 RNA export. As a test for trafficking of HIV-1 RNAs into the nucleolus, a hammerhead ribozyme that specifically cleaves HIV-1 RNA was inserted into the body of the U16 small nucleolar RNA, resulting in accumulation of the ribozyme within the nucleoli of human cells. HeLa CD4(+) and T cells expressing this nucleolar localized ribozyme exhibit dramatically suppressed HIV-1 replication. The results presented here suggest a trafficking of HIV-1 RNA through the nucleoli of human cells, thus posing a different paradigm for lentiviral RNA processing.

Indexed as

Base SequenceCell LineCell NucleolusDNA PrimersGene Products, revGene Products, tatHIV-1HumansMembrane Fusionrev Gene Products, Human Immunodeficiency VirusRNA, Catalytictat Gene Products, Human Immunodeficiency VirusDNA PrimersGene Products, revGene Products, tatrev Gene Products, Human Immunodeficiency VirusRNA, Catalytictat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID10922055
PMCPMC16803
OpenAlexW2020422048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.